Evidence map›Paper›PMID 33737115›Full record

ArticleThe Journal of infection2021

Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19.

Manuel Lorenzo López Reboiro, Rebeca Suárez Fuentetaja, Raquel Gutiérrez López, Beatriz Ares Castro-Conde, Cristina Sardiña González, Inés Navarro Menéndez, Marco Francisco Pereyra Barrionuevo, M Teresa Alves Pérez, José López Castro

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Manuel Lorenzo López ReboiroDepartment of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.
Rebeca Suárez FuentetajaDepartment of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.
Raquel Gutiérrez LópezDepartment of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.
Beatriz Ares Castro-CondeDepartment of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.
Cristina Sardiña GonzálezDepartment of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.
Inés Navarro MenéndezHematology Section, Department of Internal Medicine, Hospital Público de Monforte, Lugo,Spain.
Marco Francisco Pereyra BarrionuevoSection of Pneumology, Department of Internal Medicine, Hospital Público de Monforte, Lugo, Spain.
M Teresa Alves PérezBiostatistics, NECOM, University of Vigo, Vigo, Spain.
José López CastroDepartment of Internal Medicine, Hospital Público de Monforte, Lugo, Spain. Electronic address: jlcastro126@hotmail.com.
Universidade de Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19von Willebrand FactorHumansLupus Coagulation InhibitorSARS-CoV-2Lupus Coagulation Inhibitorvon Willebrand Factor

Identifiers

PMID33737115
PMCPMC7959681
OpenAlexW3136875605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.